Want to see POCI full AI Analyst Report?
POCI Stock Chart & Stats
$4.41
$0.00(0.00%)
At close: 4:00 PM EDT
$4.41
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$3.55 - $6.15
Previous Close$4.35
Volume24.84K
Average Volume (3M)61.71K
Market Cap
$50.53M
Enterprise Value$50.03M
Total Cash (Recent Filing)$9.84M
Total Debt (Recent Filing)$4.06M
Price to Earnings (P/E)―
Beta0.48
Next Earnings
Nov 16, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.46
Shares Outstanding10,972,792
10 Day Avg. Volume107,895
30 Day Avg. Volume61,708
Financial Highlights & Ratios
PEG Ratio0.24
Price to Book (P/B)2.14
Price to Sales (P/S)1.38
P/FCF Ratio-22.01
Enterprise Value/Market Cap0.99
Enterprise Value/Revenue1.59
Enterprise Value/Gross Profit9.21
Enterprise Value/Ebitda-15.49
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.07
Revenue Forecast (FY)$34.50M
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthThe sharp expansion in annual and production revenue indicates stronger customer demand and increasing program contribution. If sustained, this broader revenue base can improve operating leverage, support reinvestment, and strengthen Precision Optics’ position across medical, optical communications, and defense applications over the next several quarters.
Improved Manufacturing EfficiencyHigher-volume manufacturing capability is a durable operational advantage because it can improve throughput, yields, and unit economics across existing and future production lines. These process improvements may support more consistent margins and allow the company to scale customer programs without proportionate increases in operating costs.
Balance Sheet ResilienceThe stronger cash position and limited debt provide financial flexibility while the company works toward sustained profitability. Ample liquidity can help fund production ramps, absorb uneven program timing, and reduce near-term dependence on external capital, while unchanged operating expenses show some cost discipline during rapid revenue growth.
Bears Say
Persistent UnprofitabilityAlthough profitability improved in the second half, management still expects a full-year adjusted EBITDA loss and additional quarterly losses early in fiscal 2027. Continued unprofitability limits internally generated funding, leaves execution dependent on a successful recovery and ramp, and makes earnings improvement less established.
Compressed Gross MarginsThe sustained decline in gross margin indicates that revenue growth has not yet translated into comparable profitability improvement. Even with stronger recent-quarter performance, lower annual margins reduce operating leverage, increase sensitivity to product mix and ramp costs, and make the path to durable earnings more challenging.
Satellite Customer Revenue PullbackThe expected customer-driven decline creates a material near-term revenue and profit gap because the satellite program is a higher-margin contributor. Recovery timing remains uncertain, and replacing that volume with other business may not restore the same profit contribution, increasing execution and customer-concentration risk.
Precision Optics Corporation News
POCI FAQ
What was Precision Optics Corporation’s price range in the past 12 months?
Precision Optics Corporation lowest stock price was $3.55 and its highest was $6.15 in the past 12 months.
What is Precision Optics Corporation’s market cap?
Precision Optics Corporation’s market cap is $50.53M.
When is Precision Optics Corporation’s upcoming earnings report date?
Precision Optics Corporation’s upcoming earnings report date is Nov 16, 2026 which is in 33 days.
How were Precision Optics Corporation’s earnings last quarter?
Precision Optics Corporation released its earnings results on Sep 28, 2026. The company reported -$0.01 earnings per share for the quarter, beating the consensus estimate of -$0.06 by $0.05.
Is Precision Optics Corporation overvalued?
According to Wall Street analysts Precision Optics Corporation’s price is currently Overvalued.
Does Precision Optics Corporation pay dividends?
Precision Optics Corporation does not currently pay dividends.
What is Precision Optics Corporation’s EPS estimate?
Precision Optics Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Precision Optics Corporation have?
Precision Optics Corporation has 10,972,792 shares outstanding.
What happened to Precision Optics Corporation’s price movement after its last earnings report?
Precision Optics Corporation reported an EPS of -$0.01 in its last earnings report, beating expectations of -$0.06. Following the earnings report the stock price went down -5.635%.
Which hedge fund is a major shareholder of Precision Optics Corporation?
Currently, no hedge funds are holding shares in POCI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Precision Optics Corporation Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
7.54%
12-Months-Change
Fundamentals
Return on Equity
-23.92%
Trailing 12-Months
Asset Growth
63.39%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Precision Optics Corporation
Precision Optics Corporation, Inc. (POCI) specializes in the engineering, manufacturing, and sale of advanced optical and illumination systems, along with their complementary components. Its main operational regions are the United States and the European Economic Area. The company's offerings include medical instruments such as various types of endoscopes and endocouplers. Moreover, POCI provides bespoke imaging and lighting solutions, encompassing high-precision Microprecision lenses, miniature medical cameras, and cutting-edge 3D endoscopes, all designed for application in minimally invasive surgical procedures carried out by hospitals and healthcare professionals. Beyond its medical division, POCI also produces individual parts and integrated assemblies for industrial and military purposes. POCI markets its medical device portfolio primarily to other corporations within the medical technology sector. Established in 1982, the firm's headquarters are located in Gardner, Massachusetts.
POCI Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was broadly positive, supported by record fourth-quarter and full-year revenue, sharply improved production efficiency, positive adjusted EBITDA in the second half, stronger yields, new satellite and defense opportunities, and a strengthened balance sheet. The main negative factors were the expected 40% first-quarter fiscal 2027 revenue reduction from the existing satellite customer, further second-quarter reduction, lower engineering revenue, an expected fiscal 2027 adjusted EBITDA loss, and the uncertainty surrounding the timing of satellite program recovery and new program production.View all POCI earnings summariesTechnical Analysis
Ownership Overview
5.41% Insiders
17.44% Mutual Funds
24.73% Other Institutional Investors
49.24% Public Companies and
Individual Investors